Related Experiment Video
Updated: Dec 30, 2025

Development and Characterization of Fusidic Acid-Loaded Alginate-Aloe vera Based Hydrogel FilmWound Healing
Published on: December 13, 2024
Ionic Diffusion and Drug Release Behavior of Core-Shell-Functionalized Alginate-Chitosan-Based Hydrogel.
Deepak Kumar Khajuria1,2, Ramakrishna Vasireddi1, Manish Kumar Priydarshi1
1Laboratory for Integrative Multiscale Engineering Materials and Systems, Department of Aerospace Engineering, Indian Institute of Science, Bangalore 560012, India.
Researchers developed pH-responsive calcium alginate-chitosan microbeads for sustained risedronate delivery. These microbeads protect the drug in stomach acid, potentially improving effectiveness and reducing side effects.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Microfluidics
Background:
- Calcium alginate (CaALG) microbeads exhibit core-shell structures influenced by water levels, pH, and electrical conductivity.
- Developing effective drug delivery systems requires understanding material properties and controlled release mechanisms.
Purpose of the Study:
- To investigate the core-shell structure effects in CaALG microbeads concerning pH and electrical conductivity.
- To develop and test a novel microfluidic device for programmed drug release of risedronate (RIS) from CaALG-chitosan (CHT) microbeads.
- To evaluate the pH-responsive and gastro-protective properties of CaALG-CHT microbeads for RIS delivery.
Main Methods:
- Fabrication of CaALG microbeads with varying CaCl2 concentrations.
- Characterization of microbead swelling, pH, and electrical conductivity.
- Utilized a custom microfluidic device with a steplike barrier for single microbead analysis.
- Quantified RIS release using spectrophotometry at different pH levels (2.1, 4, 6.8, 7.4).
Main Results:
- Decreased CaCl2 concentration enhanced CaALG microbead swelling.
- Electrical current-voltage characteristics revealed pH-dependent ionic mobility and electrokinetic forces.
- CaALG-CHT microbeads demonstrated sustained RIS release and resistance to acidic environments.
- The microfluidic device enabled precise monitoring of drug release from individual microbeads.
Conclusions:
- CaALG-CHT microbeads offer a promising platform for sustained and pH-responsive delivery of risedronate.
- The developed microbeads can protect RIS from degradation in the stomach, potentially improving therapeutic outcomes and reducing gastric side effects.
- The novel microfluidic device is suitable for screening drugs and evaluating novel delivery systems.
More Related Videos
07:24Author Spotlight: Advancing Therapeutics with Biocompatible Sodium Alginate Hydrogel Microspheres
Published on: June 7, 2024
08:59A Freeze-Thawing Method to Prepare Chitosan-Polyvinyl alcohol Hydrogels Without Crosslinking Agents and Diflunisal Release Studies
Published on: January 14, 2020
Related Concept Videos
In Vitro Drug Dissolution: Alternative Methods
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry